SCOPUS 정보 검색 플랫폼

Heart

Volumn 97, Issue 12, 2011, Pages 1026-

Correspondence: Controversies with On-TIME 2

(4) Lin, Gen Min a Li, Yi Hwei b Chu, Kai Min c Han, Chih Lu d

a HUALIEN ARMED FORCES GENERAL HOSPITAL (Taiwan)

b TZU CHI UNIVERSITY (Taiwan)

c TRI SERVICE GENERAL HOSPITAL (Taiwan)

d TAIPEI VETERANS GENERAL HOSPITAL (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TIROFIBAN;

BLEEDING; DRUG MEGADOSE; EMERGENCY CARE; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 79956324595 PISSN: 13556037 EISSN: 1468201X Source Type: Journal
DOI: 10.1136/heartjnl-2011-300095 Document Type: Letter

Times cited : (2)

References (5)

1
- 78651248926
- High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: Results of a subgroup analysis of the On-TIME 2 trial
- Hermanides RS, Heestermans AA, Ten Berg JM, et al. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial. Heart 2011;97:106-11.
- (2011) Heart , vol.97 , pp. 106-111
- Hermanides, R.S.¹ Heestermans, A.A.² Ten Berg, J.M.³

2
- 49149128492
- Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): A multicentre, double-blind, randomized controlled trial
- Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group
- Van't Hof AW, Ten Berg J, Heestermans T, et al; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomized controlled trial. Lancet 2008;372:537-46.
- (2008) Lancet , vol.372 , pp. 537-546
- Van'T Hof, A.W.¹ Ten Berg, J.² Heestermans, T.³

3
- 33747107380
- Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction
- Smit JJ, van 't Hof AW, de Boer MJ, et al. Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction. Thromb Haemost 2006;96:190-5.
- (2006) Thromb Haemost , vol.96 , pp. 190-195
- Smit, J.J.¹ Van 't Hof, A.W.² De Boer, M.J.³

4
- 0141727688
- The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction
- DOI 10.1016/S0735-1097(03)00920-3
- Kernis SJ, Harjai KJ, Stone GW, et al. The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003;42:1173-7. (Pubitemid 37188336)
- (2003) Journal of the American College of Cardiology , vol.42 , Issue.7 , pp. 1173-1177
- Kernis, S.J.¹ Harjai, K.J.² Stone, G.W.³ Grines, L.L.⁴ Boura, J.A.⁵ Yerkey, M.W.⁶ O'Neill, W.⁷ Grines, C.L.⁸

5
- 77954159224
- Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: A meta-regression analysis of randomized trials
- Lin GM, Han CL. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J 2010;31:753-4.
- (2010) Eur Heart J , vol.31 , pp. 753-754
- Lin, G.M.¹ Han, C.L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.